Muscle layer and regional differences in autonomic innervation and responsiveness to transmitter agents in swine myometrium. 1994

T Taneike, and S Bando, and K Takasaki, and M Okumura, and H Sato, and H Teraoka, and T Kitazawa, and A Ohga
Department of Veterinary Pharmacology, Faculty of Dairy Science, Rakuno Gakuen University, Ebetsu, Japan.

1. To clarify possible regional and muscle layer differences in adrenergic innervation of swine myometrium, functional, biochemical and histochemical experiments were performed on longitudinal (LM) and circular (CM) muscle isolated from non-pregnant uteri of 84 gilts. 2. Transmural stimulation (TMS) in the presence of propranolol evoked tetrodotoxin-sensitive contractions in a frequency-dependent manner (2-20 Hz) in LM and CM. The cornual LM contractions were attenuated by phentolamine (1 microM) and by guanethidine (10 microM) though unaffected by atropine (1 microM). Contractions in cervical LM were diminished by atropine but not by phentolamine, and the corpus LM contractions were reduced incrementally by atropine and phentolamine when added sequentially. In CM, the TMS-induced contractions were abolished by tetrodotoxin and atropine in all three regions. 3. In response to noradrenaline (NA) and acetylcholine (ACh), LM contractile intensity was the most potent in cornua, slightly weaker in the corpus and weakest in the cervix. CM was insensitive to NA, and contractile responses elicited by ACh indicated no regional variation. 4. NA content, significantly greater in LM than in CM, was most highly concentrated in cornual LM. Nerves exhibiting glyoxylic acid-induced histofluorescence occurred in both LM and CM, though more abundantly in LM and with notable density in the cornual LM. Cholinesterase activity, distributed evenly throughout the three myometrial regions studied, was more intense in LM than in CM. 5. These results show that, in swine myometrium, innervation in cornual LM is predominantly noradrenergic, cervical LM is mostly cholinergic, and throughout the myometrium the CM layers are principally cholinergic.

UI MeSH Term Description Entries
D009215 Myometrium The smooth muscle coat of the uterus, which forms the main mass of the organ. Uterine Muscle,Muscle, Uterine,Muscles, Uterine,Uterine Muscles
D009638 Norepinephrine Precursor of epinephrine that is secreted by the ADRENAL MEDULLA and is a widespread central and autonomic neurotransmitter. Norepinephrine is the principal transmitter of most postganglionic sympathetic fibers, and of the diffuse projection system in the brain that arises from the LOCUS CERULEUS. It is also found in plants and is used pharmacologically as a sympathomimetic. Levarterenol,Levonorepinephrine,Noradrenaline,Arterenol,Levonor,Levophed,Levophed Bitartrate,Noradrenaline Bitartrate,Noradrénaline tartrate renaudin,Norepinephrin d-Tartrate (1:1),Norepinephrine Bitartrate,Norepinephrine Hydrochloride,Norepinephrine Hydrochloride, (+)-Isomer,Norepinephrine Hydrochloride, (+,-)-Isomer,Norepinephrine d-Tartrate (1:1),Norepinephrine l-Tartrate (1:1),Norepinephrine l-Tartrate (1:1), (+,-)-Isomer,Norepinephrine l-Tartrate (1:1), Monohydrate,Norepinephrine l-Tartrate (1:1), Monohydrate, (+)-Isomer,Norepinephrine l-Tartrate (1:2),Norepinephrine l-Tartrate, (+)-Isomer,Norepinephrine, (+)-Isomer,Norepinephrine, (+,-)-Isomer
D010646 Phentolamine A nonselective alpha-adrenergic antagonist. It is used in the treatment of hypertension and hypertensive emergencies, pheochromocytoma, vasospasm of RAYNAUD DISEASE and frostbite, clonidine withdrawal syndrome, impotence, and peripheral vascular disease. Fentolamin,Phentolamine Mesilate,Phentolamine Mesylate,Phentolamine Methanesulfonate,Phentolamine Mono-hydrochloride,Regitine,Regityn,Rogitine,Z-Max,Mesilate, Phentolamine,Mesylate, Phentolamine,Methanesulfonate, Phentolamine,Mono-hydrochloride, Phentolamine,Phentolamine Mono hydrochloride
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011433 Propranolol A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs. Dexpropranolol,AY-20694,Anaprilin,Anapriline,Avlocardyl,Betadren,Dociton,Inderal,Obsidan,Obzidan,Propanolol,Propranolol Hydrochloride,Rexigen,AY 20694,AY20694,Hydrochloride, Propranolol
D002584 Cervix Uteri The neck portion of the UTERUS between the lower isthmus and the VAGINA forming the cervical canal. Cervical Canal of the Uterus,Cervical Canal, Uterine,Ectocervix,Endocervical Canal,Endocervix,External Os Cervix,External Os of the Cervix,Uterine Cervical Canal,Cervix,Cervixes,Uterine Cervix,Canal, Endocervical,Canal, Uterine Cervical,Cervix, External Os,Cervix, Uterine,Endocervical Canals,Uterine Cervical Canals
D002802 Cholinesterases Acylcholineacylhydrolase,Cholase,Cholinesterase
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004558 Electric Stimulation Use of electric potential or currents to elicit biological responses. Stimulation, Electric,Electrical Stimulation,Electric Stimulations,Electrical Stimulations,Stimulation, Electrical,Stimulations, Electric,Stimulations, Electrical
D005260 Female Females

Related Publications

T Taneike, and S Bando, and K Takasaki, and M Okumura, and H Sato, and H Teraoka, and T Kitazawa, and A Ohga
January 1992, Japanese journal of pharmacology,
T Taneike, and S Bando, and K Takasaki, and M Okumura, and H Sato, and H Teraoka, and T Kitazawa, and A Ohga
January 1999, General pharmacology,
T Taneike, and S Bando, and K Takasaki, and M Okumura, and H Sato, and H Teraoka, and T Kitazawa, and A Ohga
December 1991, Biology of reproduction,
T Taneike, and S Bando, and K Takasaki, and M Okumura, and H Sato, and H Teraoka, and T Kitazawa, and A Ohga
June 1971, The Journal of the American Osteopathic Association,
T Taneike, and S Bando, and K Takasaki, and M Okumura, and H Sato, and H Teraoka, and T Kitazawa, and A Ohga
June 1997, Journal of veterinary pharmacology and therapeutics,
T Taneike, and S Bando, and K Takasaki, and M Okumura, and H Sato, and H Teraoka, and T Kitazawa, and A Ohga
September 1985, The Journal of physiology,
T Taneike, and S Bando, and K Takasaki, and M Okumura, and H Sato, and H Teraoka, and T Kitazawa, and A Ohga
April 1956, Minerva cardioangiologica,
T Taneike, and S Bando, and K Takasaki, and M Okumura, and H Sato, and H Teraoka, and T Kitazawa, and A Ohga
October 1982, Experimental and molecular pathology,
T Taneike, and S Bando, and K Takasaki, and M Okumura, and H Sato, and H Teraoka, and T Kitazawa, and A Ohga
February 2003, Autonomic neuroscience : basic & clinical,
T Taneike, and S Bando, and K Takasaki, and M Okumura, and H Sato, and H Teraoka, and T Kitazawa, and A Ohga
January 1980, Acta physiologica Scandinavica. Supplementum,
Copied contents to your clipboard!